Anatomic Pathology Track and Trace Solutions Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 163 SKU: IRTNTR40179

Anatomic Pathology Track and Trace Solutions Market 2024-2028

The global anatomic pathology track and trace solutions market size is estimated to grow by USD 549.67 million at a CAGR of 14.47% between 2023 and 2028. 

Anatomic pathology laboratories are witnessing growth in proactive disease diagnosis among patients with a family history and high risk of specific diseases in their heredity. A timely diagnosis of proactive diseases allows patients to initiate a consultation with physicians for frequent monitoring of disease risk and proactively indulge in activities to prevent further progress. The use of track-and-trace solutions in pathology laboratories has reduced the expenditure on healthcare and mortality rates associated with misdiagnosis and late detection of diseases globally. Furthermore, factors such as increasing disposable income and numerous awareness campaigns emphasizing the importance of timely diagnosis across the globe will increase the number of visits to doctors for regular checkups. Therefore, the rising demand for timely disease diagnosis is expected to drive the growth of the global anatomic pathology track-and-trace solutions market during the forecast period.

Technavio has segmented the market into End-user, Technology, and Geography 

  • The end-user segment includes hospital laboratories, independent and reference laboratories, and CRO and others
  • The technology segment includes barcode and RFID
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the size of the Anatomic Pathology Track and Trace Solutions Market During the Forecast Period?

To learn more about this report, Download Report Sample

Anatomic Pathology Track and Trace Solutions Market Segmentation by End-user, Technology, and Geography Analysis

End-user Analysis 

Hospital laboratories

The market share growth by the hospital laboratories segment will be significant during the forecast period. Hospital laboratories deal with a vast volume of specimens daily, which can make tracking and tracing a challenging task. The implementation of track-and-trace solutions in these laboratories helps streamline the workflow by automating data capture, reducing manual errors, and enhancing efficiency. Furthermore, track-and-trace solutions enable improved quality control in hospital laboratories. They facilitate systematic sample tracking, minimizing the risk of mislabeling, misplacement, or loss of specimens.

Get a glance at the market contribution of various segments Download PDF Sample

The hospital laboratories segment was valued at USD 165.01 million in 2018. The increasing adoption of digital pathology and laboratory automation, coupled with the growing emphasis on patient safety, data integrity, and regulatory compliance, drives the demand for robust track-and-trace solutions in hospital settings. Moreover, the implementation of track-and-trace solutions in hospital laboratories ensures accurate specimen tracking, reduces errors, and enhances patient safety, contributing to improved healthcare outcomes. Thus, such factors will drive the growth of the hospital laboratories segment in the global anatomic pathology track-and-trace solutions market during the forecast period.

Technology Analysis 

Barcode

The barcode segment held the largest share of the global anatomic pathology track-and-trace solutions market in 2023, owing to the high adoption of barcode systems among anatomic pathology laboratories due to their lower cost (compared with RFID). Tracking of anatomic pathology assets such as slides, specimens, and blocks can reduce interpretation errors, improve productivity as well as the workflow, and decrease the overall cost. The major barcode track-and-trace products used in anatomic pathology laboratories include barcode scanners, printers, labels, and labeling systems. Furthermore, the popularity of barcodes largely depends on the complexity and capabilities of the novel tracking software. Thus, such factors will drive the barcode segment in the market during the forecast period.

RFID

The RFID segment is expected to demonstrate the fastest growth in the global anatomic pathology track-and-trace solutions market. This can be attributed to various factors, such as the ability of RFID technology to track bundled specimens and heightened data security. The major RFID track-and-trace products used in anatomic pathology laboratories include RFID readers, tags, and software. Furthermore, unlike barcodes, RFID technology does not require a user to physically locate and scan tags as the RFID readers use radio frequency signals for scanning them. RFID enables the simultaneous identification of samples and automates data collection, which largely reduces human errors and workload. Thus, such factors will drive the RFID segment in the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America, being one of the leading regions in healthcare technology adoption, has witnessed a growing adoption of anatomic pathology track-and-trace solutions. This can be attributed to several factors, including the rise in chronic diseases, advancements in diagnostic technology, and the need for efficient laboratory operations. The market is driven by the rising demand for accurate and reliable diagnostic procedures. 

In addition, stringent regulations and guidelines by regulatory bodies, such as the College of American Pathologists (CAP) and the Food and Drug Administration (FDA), have contributed to the increased adoption of track-and-trace solutions. These regulations aim to ensure patient safety, minimize errors, and maintain standardized practices in diagnostic laboratories. Thus, such factors are expected to collectively drive the growth of the anatomic pathology track-and-trace solutions market in North America.

Buy Full Report Now

Key Anatomic Pathology Track and Trace Solutions Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Agilent Technologies Inc.: The company offers anatomic pathology track and trace solutions such as Companion Diagnostics and NGS for Pathologists.

  • cerebrum corp
  • Clinisys Inc.
  • CompuGroup Medical SE and Co. KGaA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Mikroscan Technologies Inc.
  • MILESTONE MEDICAL
  • PHC Holdings Corp.
  • Psyche Systems Corp
  • Sakura Finetek USA Inc.
  • Siemens Healthineers AG
  • Visiopharm AS
  • Cirdan
  • Indica Labs Inc.
  • LigoLab Information Systems
  • Pathcore Inc
  • Proscia Inc.
  • XIFIN Inc.
  • Voicebrook Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Anatomic Pathology Track and Trace Solutions Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth and forecasting. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Anatomic Pathology Track and Trace Solutions Market Drivers

The growing adoption of automated systems in laboratories is the key factor driving market growth. Market players manufacturing anatomic pathology track-and-trace products are adopting automated solutions comprising high throughput machines integrated with automated sample collection and analysis techniques. Automated techniques have facilitated rapid and high-precision results. Moreover, automation has also enabled an increase in production and a reduction in test time without compromising the quality and purity standards. 

Additionally, anatomic pathology laboratories are using workflow automation systems to considerably reduce the costs associated with labor and materials. Furthermore, the use of automated systems for device-to-device communication and digital barcoding for sample tracking will make traceability cost-effective and procedures less prone to errors. Therefore, the growing adoption of automated systems in laboratories is expected to drive the growth of the global anatomic pathology track-and-trace solutions market during the forecast period.

Significant Anatomic Pathology Track and Trace Solutions Market Trends

Digitization of healthcare is the primary trend shaping market growth. The implementation of digitization in the healthcare industry has significantly influenced market trends and analysis. Key benefits include improved coordination between doctors and patients, enhanced communication among multiple physicians, real-time access to health information, and strengthened data security. In the domain of anatomic pathology track-and-trace solutions, digitization has led to increased efficiency in the specialty, more reproducible specimens, and a noteworthy reduction in the workload of pathologists.

Furthermore, digitization of anatomic pathology laboratories also decreases the barriers between laboratories in different regions, facilitating referrals and consultations. It can also increase the accessibility of slides by various pathology laboratories and hospitals as the information from it can be stored in the cloud and retrieved from anywhere easily. Therefore, such factors are expected to positively impact the market growth during the forecast period.

Major Anatomic Pathology Track and Trace Solutions Market Challenges

The increasing cost of healthcare treatments is a challenge that affects market growth. Advances in healthcare technology have been monumental in the diagnosis, treatment, and prevention of several diseases. However, the costs of some of the technologies are partially responsible for the overall rise in healthcare costs. Technology can consume more time and money in an organization for training, support, programming, and project development, thereby proving that return on investment (ROI) is a significant risk.

In addition, certain in-vitro diagnostic tests performed by pathology laboratories for the diagnosis of conditions such as cancer and rare diseases require the use of expensive instruments, consumables, and highly trained research personnel, which increases the overall cost of such tests. The high cost of these tests reduces their adoption among patients with budget constraints. Thus, the increasing healthcare costs are expected to impede the growth of the global anatomic pathology track-and-trace solutions market during the forecast period.

Buy Now Full Report

Key Anatomic Pathology Track and Trace Solutions Market Customer Landscape

The market report includes the adoption lifecycle of the market forecast, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Anatomic Pathology Track and Trace Solutions Market Customer Landscape

Segment Overview

The anatomic pathology track and trace solutions market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends from 2018 to 2028. 

  • End-user Outlook
    • Hospital laboratories
    • Independent and reference laboratories
    • CRO and others
  • Technology Outlook
    • Barcode
    • RFID
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Australia
      • Brazil

Anatomic Pathology Track and Trace Solutions Market Scope

Report Coverage

Details

Page number

163

Base year

2023

Historic period

2018-2022

Market forecasting period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 14.47%

Market Growth 2024-2028

USD 549.67 million

Market structure

Fragmented

YoY growth 2023-2024(%)

12.84

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, Germany, UK, France, and China

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., cerebrum corp, Clinisys Inc., CompuGroup Medical SE and Co. KGaA, Danaher Corp., F. Hoffmann La Roche Ltd., Mikroscan Technologies Inc., MILESTONE MEDICAL, PHC Holdings Corp., Psyche Systems Corp, Sakura Finetek USA Inc., Siemens Healthineers AG, Visiopharm AS, Cirdan, Indica Labs Inc., LigoLab Information Systems, Pathcore Inc, Proscia Inc., XIFIN Inc., and Voicebrook Inc.

Market dynamics

Parent market research and growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Anatomic Pathology Track and Trace Solutions Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the anatomic pathology track and trace solutions market between 2024 and 2028
  • Precise estimation of the anatomic pathology track and trace solutions market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of anatomic pathology track and trace solutions market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global anatomic pathology track and trace solutions market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global anatomic pathology track and trace solutions market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Technology Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Technology Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospital laboratories - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospital laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Hospital laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Hospital laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospital laboratories - Year-over-year growth 2023-2028 (%)
    • 6.4 Independent and reference laboratories - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Independent and reference laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Independent and reference laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Independent and reference laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Independent and reference laboratories - Year-over-year growth 2023-2028 (%)
    • 6.5 CRO and others - Market size and forecast 2023-2028
      • Exhibit 42: Chart on CRO and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on CRO and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on CRO and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on CRO and others - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Technology

    • 7.1 Market segments
      • Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
    • 7.2 Comparison by Technology
      • Exhibit 50: Chart on Comparison by Technology
      • Exhibit 51: Data Table on Comparison by Technology
    • 7.3 Barcode - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Barcode - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Barcode - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Barcode - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Barcode - Year-over-year growth 2023-2028 (%)
    • 7.4 RFID - Market size and forecast 2023-2028
      • Exhibit 56: Chart on RFID - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on RFID - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on RFID - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on RFID - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Technology
      • Exhibit 60: Market opportunity by Technology ($ million)
      • Exhibit 61: Data Table on Market opportunity by Technology ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 France - Market size and forecast 2023-2028
      • Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 111: Agilent Technologies Inc. - Overview
              • Exhibit 112: Agilent Technologies Inc. - Business segments
              • Exhibit 113: Agilent Technologies Inc. - Key offerings
              • Exhibit 114: Agilent Technologies Inc. - Segment focus
            • 12.4 cerebrum corp
              • Exhibit 115: cerebrum corp - Overview
              • Exhibit 116: cerebrum corp - Product / Service
              • Exhibit 117: cerebrum corp - Key offerings
            • 12.5 Clinisys Inc.
              • Exhibit 118: Clinisys Inc. - Overview
              • Exhibit 119: Clinisys Inc. - Product / Service
              • Exhibit 120: Clinisys Inc. - Key offerings
            • 12.6 CompuGroup Medical SE and Co. KGaA
              • Exhibit 121: CompuGroup Medical SE and Co. KGaA - Overview
              • Exhibit 122: CompuGroup Medical SE and Co. KGaA - Business segments
              • Exhibit 123: CompuGroup Medical SE and Co. KGaA - Key offerings
              • Exhibit 124: CompuGroup Medical SE and Co. KGaA - Segment focus
            • 12.7 Danaher Corp.
              • Exhibit 125: Danaher Corp. - Overview
              • Exhibit 126: Danaher Corp. - Business segments
              • Exhibit 127: Danaher Corp. - Key news
              • Exhibit 128: Danaher Corp. - Key offerings
              • Exhibit 129: Danaher Corp. - Segment focus
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Mikroscan Technologies Inc.
              • Exhibit 135: Mikroscan Technologies Inc. - Overview
              • Exhibit 136: Mikroscan Technologies Inc. - Product / Service
              • Exhibit 137: Mikroscan Technologies Inc. - Key offerings
            • 12.10 MILESTONE MEDICAL
              • Exhibit 138: MILESTONE MEDICAL - Overview
              • Exhibit 139: MILESTONE MEDICAL - Product / Service
              • Exhibit 140: MILESTONE MEDICAL - Key offerings
            • 12.11 PHC Holdings Corp.
              • Exhibit 141: PHC Holdings Corp. - Overview
              • Exhibit 142: PHC Holdings Corp. - Business segments
              • Exhibit 143: PHC Holdings Corp. - Key offerings
              • Exhibit 144: PHC Holdings Corp. - Segment focus
            • 12.12 Psyche Systems Corp
              • Exhibit 145: Psyche Systems Corp - Overview
              • Exhibit 146: Psyche Systems Corp - Product / Service
              • Exhibit 147: Psyche Systems Corp - Key offerings
            • 12.13 Sakura Finetek USA Inc.
              • Exhibit 148: Sakura Finetek USA Inc. - Overview
              • Exhibit 149: Sakura Finetek USA Inc. - Product / Service
              • Exhibit 150: Sakura Finetek USA Inc. - Key offerings
            • 12.14 Siemens Healthineers AG
              • Exhibit 151: Siemens Healthineers AG - Overview
              • Exhibit 152: Siemens Healthineers AG - Business segments
              • Exhibit 153: Siemens Healthineers AG - Key news
              • Exhibit 154: Siemens Healthineers AG - Key offerings
              • Exhibit 155: Siemens Healthineers AG - Segment focus
            • 12.15 Visiopharm AS
              • Exhibit 156: Visiopharm AS - Overview
              • Exhibit 157: Visiopharm AS - Product / Service
              • Exhibit 158: Visiopharm AS - Key offerings
            • 12.16 Voicebrook Inc.
              • Exhibit 159: Voicebrook Inc. - Overview
              • Exhibit 160: Voicebrook Inc. - Product / Service
              • Exhibit 161: Voicebrook Inc. - Key offerings
            • 12.17 XIFIN Inc.
              • Exhibit 162: XIFIN Inc. - Overview
              • Exhibit 163: XIFIN Inc. - Product / Service
              • Exhibit 164: XIFIN Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 165: Inclusions checklist
                • Exhibit 166: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 167: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 168: Research methodology
                • Exhibit 169: Validation techniques employed for market sizing
                • Exhibit 170: Information sources
              • 13.5 List of abbreviations
                • Exhibit 171: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis